The pathogens considered most dangerous to human health included Aspergillus fumigatus, which comes from mold and infects the ...

Invasive fungal infections (IFIs) represent a serious and often overlooked threat to human health. These systemic infections occur when fungi, typically present in the environment, establish ...

Bacteria and fungi coexist in microbial communities in nearly all environments, from our bodies to the ocean depths. But when ...

The T2Candida Panel is the only FDA-cleared diagnostic test able to detect sepsis-causing Candida species directly-from-blood, in just 3-5 hours, without the need to wait days for a positive blood ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of ...

Candida species cause non-serious infections like thrush in tens of millions of people per year. But of more concern are the 700,000 invasive infections that can kill people, about half of which are ...

Initial funding of USD 29 million to support development of Basilea's clinical stage first-in-class antifungals, fosmanogepix and BAL2062 -- ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...

T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today provided an update on its new product development ...

Rezafungin acetate is under clinical development by Napp Pharmaceuticals and currently in Phase III for Aspergillosis.

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of scientists from the around the world has warned. According to the scientists ...

Initial funding of USD 29 million to support development of Basilea's clinical stage first-in-class antifungals, fosmanogepix a ...